An international partnership designed to improve equality in access to genomic medicine for a rare disease has now provided ...

For years, genetic testing has been treated as something rare and exceptional—a highly specialized tool ordered only by ...

On-site automated NGS using circulating tumor DNA enabled comprehensive genomic testing in ~27 hours, substantially shortening the interval between diagnosis and potential targeted-therapy selection.

Heather Quintana Suchan says early biomarker testing at diagnosis helped match her to Rybrevant and urges patients to personalize care and stay active during treatment. Heather Quintana Suchan, a ...

A program between the Medical College of Wisconsin and UW-Madison is expanding genomic testing for newborns in NICUs to more Wisconsin hospitals. The Badger Baby Network trains neonatologists to ...

For the more than 300,000 women diagnosed with breast cancer each year, one of the biggest challenges is uncertainty around treatment options. Treatment isn’t one-size-fits-all and often comes with ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Advances in genomic science are reshaping how cancer is ...

NICE, France — Advanced genomic testing could help erase significant disparities in breast cancer survival rates between white and Black patients, new research has found. Currently, Black women in the ...

Elsa Pataky has long been an advocate for healthy living. Now, the Spanish actress opens up about healthy ageing, ...

Tens of thousands of patients with lung cancer in the United Kingdom are missing out on targeted treatment that could improve their prognosis due to delays in genomic testing, a new report has warned.

GeneDx leverages a vast rare disease database and advanced genomic testing, offering superior insights over traditional panel testing. The company achieved a significant turnaround, becoming cash flow ...